Janssen-Cilag International NV

Quick facts

Marketed products

• OROS hydromorphone HCl · Pain Management
  OROS hydromorphone HCl is an extended-release opioid agonist that binds to mu-opioid receptors in the central nervous system to provide sustained pain relief.

Phase 3 pipeline

• darunavir (DRV, TMC114) · Infectious diseases
  Darunavir is a protease inhibitor that blocks the protease enzyme in HIV, preventing viral replication.
• double blind PR OROS methylphenidate · Central Nervous System
  Methylphenidate is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain.
• open label PR OROS methylphenidate · Attention deficit hyperactivity disorder
  Methylphenidate is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain.

Phase 1 pipeline

• JNJ-55308942 High Dose

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Janssen-Cilag International NV portfolio CI brief
• Janssen-Cilag International NV pipeline updates RSS